Our 
Story

SteroTherapeutics, a Philadelphia-based, privately held biopharmaceutical company, is developing novel therapeutics for rare diseases with the strategic intent to further develop the therapeutics for larger, more common diseases. The company will combine its small company efficiencies with the development advantages afforded initially by the Orphan Drug Act; and subsequently, faster development pathways for the mainstream indications.


With our experienced management team and renowned scientific advisory board, we believe our programs have the potential to treat both large and small unmet medical diseases. Further, our partnerships with world-class leaders in academia and research will ensure our success in achieving our mission.

 

The company's strategic intent is to focus on platform technologies and corresponding disease pathways in diseases with significant unmet or underserved medical needs.  In each individual target, SteroTherapeutics embraces the opportunity to provide safe, effective treatments, and restore an optimal quality of life.

 

SteroTherapeutics currently has three programs underway utilizing this strategy:  ST-002, ST-003, and ST-004.

Our Team

ManoharKatakam.jpg

Manohar Katakam 
PH.D.

Founder & CEO

Dave-Johnston.webp

David Johnston

Chief Financial Officer

Lisa head shot.JPG

Lisa Sher

Head of Corporate Development

BoAllen.jpg

Bo Allen
PH.D.

Senior VP, Regulatory Affairs

ArthurSchwartz.jpg

Arthur Schwartz
PH.D.

Sr VP, Scientific Affairs

Scientific Advisory Board

Roberto Salvatori.webp

Professor of Medicine, Johns Hopkins University

Honors, Catholic

 

University School of Medicine in Rome, Italy

W Bryan Burnette.webp

W. Bryan Burnette
MD

Associate Professor,

University of Vanderbilt

Arun.webp

Arun J. Sanyal
MD, FAASLD

Virginia Commonwealth University, Richmond, VA

Scott Friedman.webp

Scott L. Friedman
MD

Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases at Icahn School of Medicine at Mount Sinai

Andre Lax.webp

Andre Lacroix
MD

Endocrinology, Centre hospitalier de l’Université de Montréal (CHUM), Montreal